From: The development and validation of oral cancer staging using administrative health data
Female | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Stage I versus II-IV | Stage I-II versus III-IV | Stage I-III versus IV | ||||||||
Stage I | Stage I-II | Stage I-III | ||||||||
N | % | P-value | N | % | P-value | N | % | P-value | ||
Age | 0.2566 | 0.4916 | 0.4026 | |||||||
20-44 | 6 | 54.55 | 6 | 54.55 | 8 | 72.73 | ||||
45-64 | 10 | 31.25 | 11 | 34.38 | 16 | 50.00 | ||||
> = 65 | 8 | 27.59 | 11 | 37.93 | 15 | 51.72 | ||||
Site | 0.0015 | <.0001 | 0.0005 | |||||||
Lip | 2 | 50.00 | 3 | 75.00 | 3 | 75.00 | ||||
Tongue | 16 | 59.26 | 19 | 70.37 | 23 | 85.19 | ||||
Gingiva | 1 | 12.50 | 1 | 12.50 | 2 | 25.00 | ||||
Floor of mouth | 2 | 50.00 | 2 | 50.00 | 2 | 50.00 | ||||
Others | 3 | 10.34 | 3 | 10.34 | 9 | 31.03 | ||||
Treatment | ||||||||||
S | 17 | 60.71 | 20 | 71.43 | 24 | 85.71 | ||||
RT | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | ||||
CT | 0 | 0.00 | 0 | 0.00 | 3 | 15.79 | ||||
S + RT | 4 | 57.14 | 4 | 57.14 | 6 | 85.71 | ||||
S + CT | 2 | 18.18 | 3 | 27.27 | 5 | 45.45 | ||||
RT + CT | 1 | 25.00 | 1 | 25.00 | 1 | 25.00 | ||||
S + RT + CT | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 |